• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT XIENCE ALPINE EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT XIENCE ALPINE EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT SYSTEM Back to Search Results
Model Number 1125350-18
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Hypersensitivity/Allergic reaction (1907)
Event Date 04/26/2017
Event Type  Injury  
Manufacturer Narrative
(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.The device was not returned for evaluation.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.The reported patient effects of hypersensitivity is listed in xience alpine everolimus eluting coronary stent systems instructions for use as known patient effects of coronary stenting procedures.A conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.There is no indication of a product quality issue with respect to manufacture, design or labeling.The xience alpines (3.5 x 28 and 3.0 x 38) referenced are filed under separate medwatch report numbers.
 
Event Description
It was reported that the procedure the patient underwent was to treat an unspecified coronary artery.Three xience alpine stents were implanted on (b)(6) 2017: 3.5 x 28 mm, 3.0 x 38 mm and 3.5 x 18 mm.Approximately 2-3 days post stenting procedure, the patient began experiencing hives, rashes, itching and bruising (from scratching) all over her body and was re-hospitalized on (b)(6) 2017 due to her symptoms.The patient was released from the hospital on (b)(6) 2017.She has seen 4 specialists (cardiologist, internist, dermatologist and allergist), and it was thought that the adverse reaction is likely due to the drug (everolimus) on these stents.The patient has no medical history of allergies.She underwent a stenting procedure approximately 8 years ago, with implantation of one stent; the patient did not experience any adverse effects afterwards.The dosage of her medications have been increased.She was prescribed epifoam and vistaril, as well as prednisone.Her physician originally prescribed plavix; this was changed to brilinta.The brilinita was then changed to effient, which continues.Before the three xience alpine implants, the patient was taking baby aspirin but this was discontinued after the procedure.There was no adverse patient sequela reported.No additional information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE ALPINE EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Type of Device
DRUG ELUTING CORONARY STENT SYSTEM
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 4628
Manufacturer (Section G)
CLONMEL, IRELAND REG# 9616693
abbott vascular
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
connie speck
abbott vascular
26531 ynez road
temecula, CA 92591-4628
9519143996
MDR Report Key6699151
MDR Text Key79570983
Report Number2024168-2017-05748
Device Sequence Number1
Product Code NIQ
UDI-Device Identifier08717648199530
UDI-Public(01)08717648199530(17)190608(10)6060141
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer
Reporter Occupation Health Professional
Remedial Action Other
Type of Report Initial
Report Date 07/10/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/10/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date06/08/2019
Device Model Number1125350-18
Device Catalogue Number1125350-18
Device Lot Number6060141
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/28/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/01/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age80 YR
Patient Weight79
-
-